Antimetabolites: all 7,305 studies that test it
Page 43 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal CancerStatus unknownNCT02919878Phase 2
- Nordic Pancreatic Cancer Trial (NorPACT) - 1Active, not recruitingNCT02919787Phase 2/3
- PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early StageStatus unknownNCT02918747Phase 2
- Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATGCompletedNCT02916979Phase 1
- Lenvatinib and Capecitabine in Patients With Advanced MalignanciesWithdrawnNCT02915172Phase 1
- Thiopurine EnhAnced Maintenance TherapyCompletedNCT02912676Phase 1/2
- PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic CancerTerminatedNCT02910882Phase 2
- Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal CancerTerminatedNCT02910843Phase 1
- Mercaptopurine Therapy in Ulcerative ColitisStatus unknownNCT02910245Phase 3
- Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)CompletedNCT02905188Phase 1
- Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children with Recurrent Posterior Fossa Brain TumorsCompletedNCT02905110Early Phase 1
- Conventional Microneedling vs Microneedling With 5-FU (MMP) for Idiopathic Guttate Hypomelanosis (IGH) RepigmentationStatus unknownNCT02904564Phase 4
- Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP)CompletedNCT02902861Phase 3
- Pembrolizumab, Trastuzumab, HER2 Positive Gastric CancerStatus unknownNCT02901301Phase 1/2
- Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast CancerSuspendedNCT02897050Phase 2
- 2-week dc of MTX and Influenza Vaccination in RAStatus unknownNCT02897011Not applicable
- Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 StudyStatus unknownNCT02894645Phase 4
- Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRCStatus unknownNCT02893540Phase 2/3
- Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AMLCompletedNCT02891278Phase 1
- Lesinurad/Allopurinol 200/300 FDC Tablets BioequivalenceCompletedNCT02888054Phase 1
- EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLCStatus unknownNCT02886195Phase 3
- Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder CancerCompletedNCT02885974Phase 1
- Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified TreatmentCompletedNCT02881086Phase 3
- A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma.Status unknownNCT02878889Phase 2
- Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell CarcinomaStatus unknownNCT02876978Phase 1
- Ph 1 Study of ADI-PEG 20 Plus Low Dose Cytarabine in Older Patients With AMLTerminatedNCT02875093Phase 1
- SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal CancerStatus unknownNCT02870153Phase 2
- Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric CancerTerminatedNCT02867839Phase 3
- A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT02867306Phase 1
- Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal CancerCompletedNCT02864849Phase 2
- Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of PancreascarcinomaStatus unknownNCT02863471Phase 1/2
- A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic CancerStatus unknownNCT02863367Phase 2
- Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT02861417Phase 2
- Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell CancerCompletedNCT02860819Phase 2
- EDOCH Alternating With DHAP for New Diagnosed Younger MCLCompletedNCT02858804Phase 4
- Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic CholangiocarcinomaWithdrawnNCT02856568Phase 1
- Reduce Risk for Crohn's Disease PatientsCompletedNCT02852694Phase 4
- Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal CancerCompletedNCT02848443Phase 1
- Optimal Treatment Strategy Based on for Pediatric AMLStatus unknownNCT02848183Phase 2
- p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic CancerCompletedNCT02847000Early Phase 1
- p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid MalignanciesCompletedNCT02846935Early Phase 1
- To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast CancerCompletedNCT02846428Phase 2
- POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGCCompletedNCT02845908Phase 2
- LBL-2016 for Children or Adolescents in ChinaActive, not recruitingNCT02845882Phase 3
- Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic AnemiaCompletedNCT02845596Not applicable
- Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma MultiformeStatus unknownNCT02844062Phase 1
- Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell CancerTerminatedNCT02842125Phase 1/2
- Trial of Bortezomib, Cytarabine, and Dexamethasone in Mantle Cell LymphomaCompletedNCT02840539Phase 2
- Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyWithdrawnNCT02839694Phase 1
- Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPMTerminatedNCT02838745Phase 1
- X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast CancerStatus unknownNCT02838238Phase 2
- Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid ArthritisStatus unknownNCT02837146Phase 3
- A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)WithdrawnNCT02835794Phase 1/2
- Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.CompletedNCT02834559Phase 3
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
- Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)WithdrawnNCT02829840Phase 1/2
- Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe PsoriasisTerminatedNCT02829424Phase 4
- Microalbuminuria and Allopurinol in Type 1 DiabetesCompletedNCT02829177Phase 4
- Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell LymphomaCompletedNCT02825147Phase 2
- Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic MelanomaCompletedNCT02816021Phase 2
- S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal CancerCompletedNCT02813967Phase 3
- Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer PatientsCompletedNCT02812992Phase 4
- Study of Azacitidine and Durvalumab in Advanced Solid TumorsCompletedNCT02811497Phase 2
- A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer SubjectsCompletedNCT02797977Phase 1/2
- Investigation of the Atherogenic Effects of Uric Acid-modified in Endothelial Dysfunction and the the Preventional Mechanism by AnthocyanidinesStatus unknownNCT02797028Phase 4
- Vinorelbine and Gemcitabine in MyelomaCompletedNCT02791373Phase 2
- Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable ImmunodeficiencyWithdrawnNCT02789397Phase 2
- Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical TrailTerminatedNCT02789189Phase 2
- A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung CancerStatus unknownNCT02787473Phase 2
- Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02786641Phase 3
- Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic SyndromeWithdrawnNCT02783547Phase 1
- A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)Status unknownNCT02779569Not applicable
- Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedNCT02779283Phase 1
- Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader CarcinomaCompletedNCT02778308Not applicable
- CNS Prophylaxis in Diffuse Large B-cell LymphomaStatus unknownNCT02777736Phase 3
- HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning RegimenStatus unknownNCT02776202Phase 2
- MEK162 in Combination With Capecitabine in Advanced Biliary Tract CancerCompletedNCT02773459Phase 1/2
- D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant DepressionStatus unknownNCT02772211Phase 4
- Glutamate, Learning, and Working MemoryCompletedNCT02769936Phase 1
- SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell AnemiaCompletedNCT02769845Not applicable
- Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell LymphomaStatus unknownNCT02767674Phase 3
- Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast CancerCompletedNCT02767661Phase 3
- Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After ResectionStatus unknownNCT02767375Phase 2/3
- The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy SurgeryCompletedNCT02767219Phase 3
- NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/AdolescentsCompletedNCT02763475Phase 2
- Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02761291Phase 1
- CyBeR Association in Relapsed/Refractory DLBCLStatus unknownNCT02758925Phase 2
- Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AMLCompletedNCT02750995Phase 1
- Azacitidine in Haploidentical Donor Hematopoietic Cell TransplantationTerminatedNCT02750254Phase 1
- Study of ONO-4538 in Gastric CancerCompletedNCT02746796Phase 2/3
- G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCTCompletedNCT02744742Phase 2/3
- Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid ArthritisCompletedNCT02744196Phase 3
- Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung CancerStatus unknownNCT02743923Phase 3
- Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the PancreasStatus unknownNCT02739633Phase 2
- Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerStatus unknownNCT02737228Phase 1/2
- Cycloserine in the Treatment of Sleep ApneaTerminatedNCT02735694Phase 1
- Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell LymphomaCompletedNCT02728531Phase 1
- Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With ChemotherapyCompletedNCT02728492Phase 1
- Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs FailureStatus unknownNCT02725918Phase 2
- Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For LymphomaWithdrawnNCT02724904Phase 1/2